Marite Punapart, (sup) Mario Plaas, Anton Terasmaa, Eero Vasar.Effects of Valproate and Liraglutide in Rodent Models of Wolfram Syndrome: Emphasis on Transcriptomic Changes in the Renin-Angiotensin-Aldosterone System. University of Tartu, Faculty of Medicine.
Vootele Võikar, 2006, (sup) Eero Vasar, Heikki Rauvala. Evaluation of Methods and Applications for Behavioural Profiling of Transgenic Mice. University of Helsinki.
Alar Veraksitš, 2003, (sup) Jaak Maaroos, Eero Vasar. Characterization of behavioural and biochemical phenotype of cholecystokinin-2 receptor deficient mice: changes in the function of the dopamine- and endopioidergic system. University of Tartu, Faculty of Medicine.
Sulev Kõks, 1999, (sup) Eero Vasar. Cholecystokinin (CCK) - induced anxiety in rats: influence of environmental stimuli and involvement of endopioid mechanisms and serotonin. University of Tartu, Faculty of Biology and Geography.
Vallo Volke, 1999, (sup) Eero Vasar. Pharmacological and biochemical studies on nitric oxide in the regulation of behaviour. University of Tartu, Faculty of Medicine.
Aavo Lang, 1995, (sup) Eero Vasar. The role of dopamine, 5-hydroxytryptamine, sigma and NMDA receptors in the action of antipsychotic drugs. University of Tartu, Faculty of Medicine.
Jaanus Harro, 1990, (sup) Lembit Allikmets, Eero Vasar. On the role of cholecystokinin and benzodiazepine receptors in the mechanism of action of anxiogenic and anxiolytic drugs. University of Tartu, Faculty of Medicine.
Andres Soosaar, 1989, (sup) Eero Vasar, Lembit Allikmets. The role of the brain cholecystokinin(CCK-8)-ergic mechanisms in the regulation of behaviour and in the action of antipsychotic drugs. University of Tartu, Faculty of Medicine.